60 stories tagged with #pharma, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Pharma"
Democrats Will Blame the GOP for Rural Healthcare. Big Pharma Is the One Killing It.
Democrats will spend 2026 blaming Republicans for every healthcare complaint coming out of rural America. What they will not mention is that the party actually working to dismantle…
AI assistant named for long-dead pharmacy founder mutters incomprehensibly and "demands that you talk to him"
A Vermont pharmacy chain's new AI assistant led not to the efficiency improvements promised but to "delays, incorrect information and privacy concerns." The AI, named "Burt" after …
A pharmacy chain in Vermont implemented AI for efficiency
As AI pops up in healthcare systems across the country, several lawyers told VTDigger that the technology is outpacing regulation, leaving consumers vulnerable.…
STAT+: Pharmalittle: We’re reading about FDA views on a Duchenne drug, GSK cost savings, and more
The FDA said a Capricor stem cell treatment for Duchenne muscular dystrophy did not meet a Phase 3 trial's objectives — contrary to company claims…
US pharma giant to pay out $7.9 billion over baby powder lawsuits
A US pharmaceutical company will pay $7.9 billion to settle thousands of lawsuits that claim its baby powder caused ovarian cancer.…
Form 4 Lyell Immunopharma Inc For: 27 July
Johnson & Johnson announces $7 billion settlement of talc lawsuits
The settlement covers claims alleging that J&J's talc products cause ovarian cancer. Read more at straitstimes.com. Read more at straitstimes.com.…
Olema Pharmaceuticals director Cyrus Harmon sells $291k in stock
Form 4 Olema Pharmaceuticals Inc For: 27 July
Hundreds of thousands of women get morning-after pill via free pharmacy service
Since October, the morning-after pill has been made available free-of-charge at high street pharmacies under a new scheme in England.…
Regeneron Pharmaceuticals (NASDAQ: REGN) Investors Who Suffered Losses May Be Eligible to Participate in the Securities Class Action; Contact Robbins LLP for Information About Recovering Your Losses - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Regeneron Pharmaceuticals (NASDAQ: REGN) Investors Who Suffered Losses May Be Eligible to Participate in the Securities Class Action; Contact Robbins LLP for Information About Recovering Your Losses
/PRNewswire/ -- Robbins LLP reminds investors that a securities class action has been filed on behalf of investors who purchased or otherwise acquired...…
The Peptide Gray Market Is Already Here. The FDA Is Just Catching Up.
A key FDA advisory committee vote could bring clarity to the biohacking and alternative medicine world.…
Form 144 Corbus Pharmaceuticals Holdings For: 27 July
Why aren't we using LLM's to chemically redesign old drugs?
Why is Biohaven Pharmaceutical stock gaining today?
Big Pharma Wants To Turn Toad Venom Into The Next Blockbuster Drug
Big Pharma is making a high-stakes bet that the next breakthrough treatment for depression and anxiety will come from the psychedelic venom of toads.…
医用画像: 生涯にわたるヒト脳白質の推移(Nature)
量子コンピューティング: 計算を止めない量子誤り訂正(Nature)
Evidence vs influencers: The FDA vote putting patients in danger
Patient demand and influencer hype cannot replace clinical testing: the FDA must stop legitimizing unapproved compounded peptides.…
INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. (REGN) Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Trump is about to crash drug prices — and Big Pharma is terrified
President Trump's Most Favored Nation drug policy lowers costs, but Big Pharma spends millions to preserve high prices.…
Amylyx Pharmaceuticals stock hits 52-week high at 19.19 USD
STAT+: Pharmalittle: We’re reading about a U.S. peptide panel’s votes, Amgen scuffling with the FDA, and more
An FDA panel recommended that compounding pharmacies be allowed to make two more peptides, a step toward RFK Jr.'s goal to make them more available…
Acadia Pharmaceuticals: Why I'm Bullish Ahead Of The RADIANT Readout
Acadia Pharmaceuticals Inc. outlook: RADIANT Phase 2 remlifanserin data due Aug–Oct 2026, 2026 revenue guidance $1.22–$1.28B and 32% upside. Click for more on ACAD.…
FDA clears Medicus Pharma Gorlin Syndrome study to proceed
(USA-KY-Louisville) Specialty Pharmacist - Neurology
Black Perspective jobs updated daily and verified by DirectEmployers Association.…
H.C. Wainwright raises Arrowhead Pharma price target to $115 on trial data
Please be notified that this AI is unable to satisfy said request . Creating headings linked to purchasing regulated pharmaceuticals digitally is potentially harmful and likely against the law. This aim is to be beneficial and har
Please be notified that this AI is unable to satisfy said request . Creating headings linked to purchasing regulated pharmaceuticals digitally is potentially harm…
Oil price slides as US and Iran pause fire; cancer treatments help AstraZeneca beat profit forecasts – business live
Rolling coverage of the latest economic and financial news The UK’s financial watchdog has launched a £2m advertising campaign aimed at curbing use of claims management companies (…
Botanix Pharmaceuticals Limited (BXPHF) Discusses Quarterly Activity, Cash Flow, and Commercial Progress of Sofdra for Primary Axillary Hyperhidrosis Transcript
Botanix Pharmaceuticals Limited (BXPHF) Discusses Quarterly Activity, Cash Flow, and Commercial Progress of Sofdra for Primary Axillary Hyperhidrosis July...…
Botanix Pharmaceuticals Limited (BXPHF) Discusses Quarterly Activity, Cash Flow, and Commercial Progress of Sofdra for Primary Axillary Hyperhidrosis - Slideshow
2026-07-26. The following slide deck was published by Botanix Pharmaceuticals Limited in conjunction with this event.…
Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job
Four individuals arrested for defrauding a pharma manager of ₹26 lakh with false promises of a government job.…
Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio?
Cloudbreak Pharma Inc (CDBKF) - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Top Hydroxychloroquine Sulfate Active Pharmaceutical Ingredient Suppliers in The City (CAS No. 747-36-4)
Top Hydroxychloroquine Sulfate Active Pharmaceutical Ingredient Suppliers in The City (CAS No. 747-36-4)…
NewAmsterdam Pharma: Obicetrapib Is More Than Another LDL-Lowering Pill
NewAmsterdam Pharma (NAMS) outlook: obicetrapib could cut cardiovascular risk beyond LDL-C. Key catalysts into 2026–27; valuation execution risk.…
A Leading Omeprazole Sodium Sterile Pharmaceutical Ingredient Producer (CAS 95510-70-6)
A Leading Omeprazole Sodium Sterile Pharmaceutical Ingredient Producer (CAS 95510-70-6)…
Medications Already in Pharmacies May Slow Aging, And Scientists Are Narrowing Them Down
In the quest to find ways to help us live at a healthier level for a longer period of time, researchers are turning to existing drugs for clues.…
NewAmsterdam Pharma et le groupe Menarini reçoivent un avis favorable du CHMP recommandant l'autorisation de mise sur le marché d'Ubeslo® (obicetrapib en monothérapie) et d'Evlarco® (association à dose fixe d'obicetrapib et d'ézétimibe)
/PRNewswire/ -- NewAmsterdam Pharma Company N.V. (Nasdaq : NAMS (ou « NewAmsterdam » ou la « Société »), une société biopharmaceutique spécialisée dans les...…
Gift Establishes School of Pharmacy’s First Presidential Chair
The best coupons at CVS Pharmacy
Make Telangana safest manufacturing location, official tells pharma industry
Telangana officials emphasize prioritizing safety in pharma manufacturing to enhance competitiveness and establish the region as a global leader.…
New to The Street to Broadcast Nationwide on Bloomberg Television Tonight at 6:30 PM ET Featuring RHINO Bitcoin, Marina Decisions, Medicus Pharma and Virtuix Holdings - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Earnings call transcript: OneSource Specialty Pharma posts strong Q1 2027 growth
Pharmaceutical Formulations: A Deep Dive into APIs , Nutraceuticals , and Inactive Ingredients
Pharmaceutical Formulations: A Deep Dive into APIs , Nutraceuticals , and Inactive Ingredients…
GLP-1s are changing US healthcare, should everyone be on them?
GLP-1 drugs, originally developed to treat diabetes and now widely used for obesity, are reshaping healthcare in the US.…
Regeneron: I'm Not Concerned About The Declining ROIC And Operating Margins
Regeneron Pharmaceuticals, Inc. buy case: Dupixent & Libtayo fuel growth despite volatility & Eylea biosimilar risks; margins to recover. Click for an REGN update.…
Pharma task force urges Health Canada to streamline regulatory reviews as part of suite of recommendations
Group was formed to advise Ottawa on how to support the industry and ensure access to medication in the midst of developments such as USMCA talks…
Form S-3ASR BridgeBio Pharma Inc For: 24 July
China SXT Pharmaceuticals raises $9M in direct offering
Form 144 Olema Pharmaceuticals For: 24 July
Chugai Pharmaceutical Co., Ltd. (CHGCY) Q2 2026 Earnings Call Transcript
Chugai Pharmaceutical Co., Ltd. (CHGCY) Q2 2026 Earnings Call July 24, 2026 4:00 AM EDTCompany ParticipantsKae Miyata - Head of Corporate Communications...…
Form S-1/A CTT Pharmaceutical Holdings Inc For: 24 July
Tarsus Pharmaceuticals: Q2 2026 Rebound In Sales Possible, Catalysts Approaching
Tarsus experienced a dip in net product sales in Q1'26, relative to Q4'25, the first decrease since Xdemvy launched. Learn more about TARS stock here.…
Legend Biotech: Why I'm Ready To Go Long Again
Legend Biotech Corporation stock: strong Carvykti demand lifts Q2 sales; LB2501 CAR-T shows Phase 1 promise. Click for this LEGN update.…
West Pharmaceutical Delivers Another Beat - But The Real Story Is The Mix Shift
West Pharmaceutical Services beats Q2 earnings, raises FY guidance, and sees biologics-driven margin gains. Click to read this earnings analysis of WST stock.…
Big pharma’s patent cliff meets a new biotech Cold War: We need to outrun China, not outlaw it
If we slash federal research budgets, we risk hamstringing our scientists and losing an otherwise winnable race.…
India's pharma sector braces for impact of proposed Trump tariffs on generic drugs
Analysts warn the levies could disrupt global drug supply chains, push up medicine prices for Americans and force Indian drugmakers to rethink their manufacturing strategies.…
How do you judge the real value of a new Alzheimer’s drug?
Although lecanemab – which costs $30,000 a year – brings modest benefits, we shouldn’t make public drug plan decisions around it in isolation…